We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
8.00 | 0.57% | 1,408.00 | 1,403.00 | 1,414.00 | 1,426.00 | 1,365.00 | 1,400.00 | 660,233 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 952.03 | 1.91B |
Date | Subject | Author | Discuss |
---|---|---|---|
27/7/2023 13:22 | US market seeing this better than U.K. | youngers | |
27/7/2023 13:05 | It's the delay in launch and the EPS. | casholaa | |
27/7/2023 10:17 | They must understand the difference between a provision and a going concern disclosure ;) | youngers | |
27/7/2023 10:09 | Numis raised tp to 2350 fwiw | baddeal | |
27/7/2023 09:53 | That’s very much a worst case scenario that has a lot of ifs in it. More importantly the base case assumption hasn’t changed with no further provisions booked which show mgmt still expect to exit this all at the previously stated position. Only change is therefore timing with it coming into the period assessed for going concern as I read it. DYOR | youngers | |
27/7/2023 09:10 | Yes,Greg,litigation is an ever hanging sword of Damocles unfortunately.The market is mesmerised by the sobering comment in today's statement-"However, if Indivior Inc. were found liable in respect of the remaining claims filed by various private plaintiffs alleging violations of civil antitrust laws and other claims relating to the Group's marketing of SUBOXONE Film (the "Antitrust MDL"), if the Plaintiffs were awarded damages, and if the Group were to be unable to significantly reduce the claimed damages at trial or in any subsequent proceeding (and considering treble damages to be awarded under U.S. antitrust laws), then the Group's financial position, results and future cash flows would be materially adversely affected and the amount of damages would exceed the Group's resources to pay. There is a reasonable prospect the timing of any appeal (or any subsequent proceeding) and/or required payment of the damages could now fall within the going concern period. | steeplejack | |
27/7/2023 09:01 | I am afraid the market reaction is the never ending litigation issues and the way the company has spelt it out in the notes this time. Nothing has changed according to the company but investors are bound to run from comments such as these.I am dissappointed to see this given I remain a LT holder | gregmorg | |
27/7/2023 08:42 | Share price movement makes no sense. Excellent set of results and upgraded guidance | youngers | |
27/7/2023 08:21 | tend to agree jack was expecting a trend up | adrian j boris | |
27/7/2023 08:18 | For the greater part,nowadays i find the reaction of the market to reported results near unfathomable.If technical analysis gives some sort of insight,i'm more than grateful.Yesterday on Wall St,Thermo Scientific's results were initially greeted with a near 7% fall.The shares ended higher. | steeplejack | |
27/7/2023 07:52 | will we have a resistance to 1984 | adrian j boris | |
27/7/2023 07:39 | Updated FY 2023 GuidanceThe Group is updating its FY 2023 guidance to primarily reflect 1) increased NR expectations for SUBLOCADE based on the strong H1 2023 performance and expectations for the remainder of the year and 2) increased NR expectations for SUBOXONE Film due to the anticipated delayed timing of an approved fourth generic buprenorphine/naloxo | steeplejack | |
23/6/2023 16:16 | actually its held up pretty well, nearly all others shares are massively down | timmy11 | |
23/6/2023 14:41 | Interest in the US has all but evaporated.The management must be a bit disappointed. | steeplejack | |
13/6/2023 16:06 | They know it makes sense, possibly had some fomo too hehehe | casholaa | |
13/6/2023 16:03 | Morgan Stanley increased their holding. Interesting. | pngasef | |
12/6/2023 17:27 | Early days.Hopefully the bell ringing on Wednesday will get the ball rolling.Perhaps this will mimic GW Pharmaceuticals that listed on Nasdaq back in 2016.GW was acquired by Jazz Pharmaceuticals in 2021 for a handsome sum of around $7bn.There’s a lot of money washing around the US drug industry. | steeplejack | |
12/6/2023 16:04 | Volume negligible at 14k shares vs 509k in the UK, will take a set of results to get this on the radar IMO. | 74tom | |
12/6/2023 14:50 | Nice pop on Nasdaq. Good arbitrage opportunity to U.K. already | youngers | |
12/6/2023 12:46 | If you wish me to put certain new info in header please ask | waldron | |
12/6/2023 12:42 | That ticker symbol i posted was wrong,sorry….i | steeplejack | |
12/6/2023 11:22 | Mm, Maybe, but there's a long way to go for the shares to even reach the previous high ( £5 in old format before 5 for one consolidation!)Plus of course, that must be something like five years ago when a pound was worth something more?!!. Still, we shall see. Dreams not built in a day! | gregmorg | |
12/6/2023 08:53 | Ding dong! | steeplejack |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions